Biogen Quote - 0R1B

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

277.67

Bid

0.00

Ask

0.00

Volume

2,481

0.00 Day's Range 0.00

277.67 52 Week Range 277.67

Market Cap

40.462B

Previous Close

277.67

Open

Last Trade

140.0168

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

3,534

Shares Outstanding

145,719,000

Dividend Yield

PE Ratio

12.50

Earnings Per Share (EPS)

11.2

Revenue

9.68B

Net Profit

1.63B

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.biogen.com

Headquarters

Wilmington, Delaware, USA

Founded

Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R1B. The last closing price for Biogen was US$277.67. Over the last year, Biogen shares have traded in a share price range of US$ 277.67 to US$ 277.67.

Biogen currently has 145,719,000 shares outstanding. The market capitalization of Biogen is US$40.46 billion. Biogen has a price to earnings ratio (PE ratio) of 12.50.

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients Global...

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare...

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE...

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Once every four weeks maintenance...

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA Applications are based on data from the DEVOTE study, which...

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s...

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus...

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD...

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	277.67	277.67	277.67	3470	277.67	DE
4	277.67	277.67	277.67	2856	277.67	DE
12	277.67	277.67	277.67	3534	277.67	DE
26	277.67	277.67	277.67	4201	277.67	DE
52	277.67	277.67	277.67	3704	277.67	DE
156	277.67	277.67	277.67	4469	277.67	DE
260	277.67	277.67	277.67	4021	277.67	DE

0R1B - Frequently Asked Questions (FAQ)

What is the current Biogen share price?

The current share price of Biogen is US$ 277.67

How many Biogen shares are in issue?

Biogen has 145,719,000 shares in issue

What is the market cap of Biogen?

The market capitalisation of Biogen is USD 40.46B

What is the 1 year trading range for Biogen share price?

Biogen has traded in the range of US$ 277.67 to US$ 277.67 during the past year

What is the PE ratio of Biogen?

The price to earnings ratio of Biogen is 12.5

What is the cash to sales ratio of Biogen?

The cash to sales ratio of Biogen is 2.11

What is the reporting currency for Biogen?

Biogen reports financial results in USD

What is the latest annual turnover for Biogen?

The latest annual turnover of Biogen is USD 9.68B

What is the latest annual profit for Biogen?

The latest annual profit of Biogen is USD 1.63B

What is the registered address of Biogen?

The registered address for Biogen is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810

What is the Biogen website address?

The website address for Biogen is www.biogen.com

Which industry sector does Biogen operate in?

Biogen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CPAICapai Plc	0.1175p (40.72%)	901.7M
XTRXtract Resources Plc	0.75p (36.36%)	9.04M
EUAEurasia Mining Plc	7.40p (32.14%)	38.22M
STBSecure Trust Bank Plc	540.00p (28.57%)	560.29k
HAYDHaydale Graphene Industries Plc	0.1325p (20.45%)	60.48M
ONCOncimmune Holdings Plc	1.15p (-27.67%)	662.94k
HRNHornby Plc	14.00p (-26.32%)	847.78k
THRUThruvision Group Plc	0.65p (-23.53%)	36.04M
DISDistil Plc	0.065p (-21.21%)	5.94M
SYMESupply@me Capital Plc	0.003p (-20.00%)	340.56M
UKOGUk Oil & Gas Plc	0.0105p (10.53%)	906.2M
CPAICapai Plc	0.1175p (40.72%)	901.7M
PREMPremier African Minerals Limited	0.01025p (-3.30%)	610.07M
ENETEthernity Networks Ltd	0.0625p (-7.41%)	484.96M
EMEEmpyrean Energy Plc	0.1225p (0.00%)	340.91M